Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Gliatech (GLIA) -- Ignore unavailable to you. Want to Upgrade?

To: Torben Noerup Nielsen who wrote (1379)	2/25/2000 2:44:00 PM
From: Dr. John M. de Castro	Read Replies (2) \| Respond to of 2001

Expectations are everything in the market. Everyone expects bad earnings. So, the fact won't upset the markets. IMHO it is the weak expected earnings that is the reason why GLIA has not participated in the biotech rally. That suggests that the earnings report and the conference call has the potential to be a strong positive force. Consider the positives that can be stated in the conference call about sales since shipments began. They are bound to be excellent if for no other reason than refilling the depleted stocks. There is the progress in reinbursements to be reported. There may be progress in the other ADCON development programs to be announced. There are also possible surprises. The bottom line is that I see a bad report as neutral while a surprise or an outstanding conference call might get us off to the races. Best regards John de C